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Amine neurotransmitters such as noradrenaline mediate arousal, attention and 
reward in the CNS. New data suggest that, from flies to mammals, a major mechanism 
for amine transmitter action is to raise astrocyte [Ca2+]i and release gliotransmitters 
that modulate neuronal activity and behaviour.   
 Classically, the amino acid neurotransmitters glutamate, GABA and glycine mediate 
rapid spatially-localised point-to-point neurotransmission. In contrast, the action of the amine 
transmitters noradrenaline, dopamine and serotonin can be more widespread, slower and 
modulatory, resulting from the amine transmitter diffusing through the extracellular space 
and acting on a spatially broader pool of cells (Fuxe et al., 2015; Moss & Bolam, 2008). In 
mammals noradrenaline release generates arousal, attention, wakefulness and fight or flight 
responses, while dopamine modulates motor function and signals some aspects of reward. 
Similarly, lower down the evolutionary tree in invertebrates, the adrenaline/noradrenaline 
analogues octopamine and tyramine promote arousal and wakefulness, mediate fight or 
flight responses, and regulate metabolism, while dopamine modulates behaviours from 
locomotion and sleep to courtship and learning. Amine transmitters have been thought to 
produce these effects by acting directly on neurons to regulate their excitability and synaptic 
strength. Surprisingly, however, recent experiments have suggested that a major contributor 
to the CNS actions of octopamine/tyramine (Oct/Tyr) in flies and of noradrenaline in 
mammals is a rise of [Ca2+]i in astrocytes, which leads to a release of factors that modulate 
neuronal function and behaviour.  
 Neurotransmitter release from neurons is one cause of astrocyte [Ca2+]i transients 
(reviewed by Bazargani & Attwell, 2016). In line with this, a new study found that, in 
Drosophila larvae, one half to three quarters of the [Ca2+]i transients in ventral nerve cord 
astrocyte cell bodies were driven by Oct/Tyr signalling from neurons which receive olfactory 
input (Ma et al., 2016). Synaptic release of Oct/Tyr led to activation of the Ca2+-permeable 
TRP channel ‘Water witch’ (Wtrw) in the astrocytes, and knockdown with RNAi of Wtrw, or 
the presence of the null allele Wtrwex, led to a halving of the astrocyte [Ca2+]i transient rate 
(with no change in the firing of Oct/Tyr neurons). Knockdown of Wtrw, or of the Oct/Tyr 
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receptor, in astrocytes also inhibited larval chemotaxis to an olfactory stimulus and startle-
induced escape responses (Ma et al., 2016). This behavioural inhibition resulted from the 
block of a pathway (Fig. 1A) in which astrocyte [Ca2+]i rises trigger a release of the 
“gliotransmitter” ATP which is converted extracellularly to adenosine and thus (probably by 
activating K+ currents or blocking Ca2+ currents) inhibits dopaminergic neurons. Since 
dopamine release suppresses movement responses by motoneurons, the overall effect of 
the Oct/Tyr - astrocyte Ca2+ pathway is to facilitate movement. Thus, with the astrocyte 
pathway blocked by deletion of Wtrw or Oct/Tyr signalling, dopaminergic neurons were 
found to fire more than normal, and the behavioural effect of this was confirmed by showing 
that the deficits in chemotaxis evoked by Wtrw knockdown could be rescued by 
administering a dopamine (D1) receptor antagonist. These data, along with previous 
experiments showing that astrocyte [Ca2+]i transients regulate synaptic gain earlier in the 
olfactory pathway (Liu et al., 2014), indicate a role for astrocyte [Ca2+]i transients in 
regulating fly behaviour.  
 In mammals, neurotransmitter-evoked [Ca2+]i rises in astrocytes have been 
suggested to release the gliotransmitters ATP (generating adenosine via ectonucleotidase 
activity), glutamate, GABA and D-serine, which act on neuronal receptors to regulate 
synaptic gain and neuronal excitability (Fig. 1B; reviewed by Bazargani & Attwell, 2016). 
Noradrenaline released from locus coeruleus axons evokes 1 receptor mediated [Ca2+]i 
rises in astrocytes (Duffy & MacVicar, 1995), which are larger than the [Ca2+]i rises evoked 
by glutamate and GABA released by local neuronal activity (Ding et al., 2013). Intriguingly, in 
visual cortex, when visually-evoked local neuronal activity and movement-evoked 
noradrenaline release occur together, the [Ca2+]i responses evoked are larger than with 
either alone (Paukert et al., 2014). It is possible that this synergy occurs at the level of the 
locus coeruleus, with the combination of movement and visual stimuli evoking more firing of 
the locus coeruleus neurons that release noradrenaline in visual cortex. Alternatively, this 
synergy might be generated locally in cortical astrocytes: when noradrenaline is being 
released from locus coeruleus axons, astrocyte [Ca2+]i rises evoked by local neuronal activity 
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may be potentiated, along with the downstream effects on neuronal function that they 
produce (see below). The spatially extensive nature of the locus coeruleus axons, together 
with the large number of synapses that each astrocyte is associated with, thus confers a 
mechanism by which information processing throughout a large region of the brain can be 
modulated - a phenomenon that could underlie context-dependent gating of attention and 
arousal by noradrenaline. 
 Examination of how [Ca2+]i is elevated in fly and rodent astrocytes reveals similarities 
between the signalling mechanisms in the different species, but also raises questions that it 
will be important to resolve in order to understand fully the function of amine transmitter 
signalling via astrocytes. In mammalian astrocytes, [Ca2+]i can be raised by 
neurotransmitters such as noradrenaline or glutamate acting on G protein coupled receptors 
that activate phospholipase C (PLC) to generate IP3 and release Ca2+ from internal stores 
(Fig. 1B). Alternatively, Ca2+ can enter across the cell membrane through ion channels such 
as ATP-gated P2X1 receptors (Mishra et al., 2017) or spontaneously active TRPA1 channels 
in astrocyte processes (Shigetomi et al., 2011). TRPA1-mediated Ca2+ entry into mammalian 
astrocytes suggests a similarity with the mechanism by which the TRP channel Wtrw 
contributes to the [Ca2+]i transients in fly astrocytes. Indeed, a BLAST homology search on 
Wtrw indicates that its closest related rodent protein is TRPA1.  
This might seem to indicate a satisfying preservation across species, by evolution, of 
an important signalling mechanism. However, there is controversy over the dependence of 
the resulting TRP-mediated [Ca2+]i transients on neuronal activity. The Drosophila larva work 
indicated that Wtrw is activated by amine neurotransmitters acting on the Oct/Tyr receptor 
on astrocytes (Ma et al., 2016), which couples to Gi and Gq proteins to inhibit adenylate 
cyclase and activate PLC (Robb et al., 1994). Activation of PLC may open Wtrw by lowering 
PIP2 level or raising [Ca2+]i, as previously reported for TRPA1 (Bellono et al., 2014; Zurborg 
et al., 2007), although Wtrw lacks the clear EF hand Ca2+-binding domain predicted (by 
http://prosite.expasy.org) to exist in TRPA1. In contrast, in young rodents TRPA1 was 
reported to be spontaneously active rather than transmitter-gated (Shigetomi et al., 2011). 
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Furthermore, two other groups have reported that in older mammalian astrocytes TRPA1 
does not contribute at all to transient [Ca2+]i signals. Rungta et al. (2016) suggested that Ca2+ 
entry occurs via a non-TRPA1 channel. Alternatively Agarwal et al. (2017) reported an 
intracellular source for many spontaneous [Ca2+]i transients, with Ca2+ being released by 
opening of the mitochondrial permeability transition pore (mPTP) in mitochondria located 
near internal store sites that release Ca2+ in response to noradrenaline. The release 
mechanism might involve Ca2+ leaving mitochondria through the mPTP itself, and perhaps 
also activation of ryanodine receptor and IP3 receptor mediated release from the adjacent 
Ca2+ stores by reactive oxygen species that are released in association with mPTP opening 
(Angelova et al., 2015; Zorov et al., 2014). Since neuronal activity localises mitochondria at 
positions in astrocyte processes that are near synapses (Stephen et al., 2015), this 
mechanism will tend to produce astrocyte [Ca2+]i transients near active synapses, i.e. 
suitable for releasing gliotransmitters onto those synapses. The different reported 
contributions of TRPA1 to mammalian astrocyte [Ca2+]i transients in these three studies 
might reflect the different ages of animal studied, difficulty in dissolving the TRPA1 blocker 
used (HC030031, which is rather insoluble), or some yet-to-be-determined difference in the 
state of the preparations.  
The controversy over the source of most astrocyte [Ca2+]i transients raises the 
important question of the main mechanism by which amine neurotransmitters raise [Ca2+]i. 
While, conventionally, this was thought to reflect release of Ca2+ from internal stores, to this 
we must now add Ca2+ entry mediated by TRP-like channels (Wtrw and TRPA1). Ca2+ 
release from mitochondria may also be increased by noradrenaline, since noradrenaline 
increases the rate of “spontaneous” [Ca2+]i transients even when the main astrocyte IP3 
receptor (IP3R2) mediating release from internal stores is knocked out (Agarwal et al., 2017). 
This increase in [Ca2+]i transients could reflect increased mPTP opening, produced when 
noradrenaline increases the rate of oxidative phosphorylation by stimulating breakdown of 
astrocyte glycogen, providing a mechanism coupling metabolism to astrocyte signalling. 
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 A key issue, for understanding how amine neurotransmitters might gate arousal, as 
outlined above, is how local release of fast transmitters such as glutamate and more global 
release of noradrenaline (and perhaps other amine transmitters) might synergistically evoke 
a [Ca2+]i signal in astrocytes that is larger than for either stimulus alone (Paukert et al., 
2014). Fast transmitters can increase astrocyte [Ca2+]i by acting on Gq-coupled receptors, or 
by activating ionotropic receptors or neurotransmitter transporters to raise [Na+]i which slows 
the action of Na+/Ca2+ exchangers (Bazargani & Attwell, 2016). In addition, Agarwal et al. 
(2017) found that an increase in neuronal activity increased the rate of mPTP opening and 
associated [Ca2+]i transients in astrocytes. More opening of the mPTP may be caused by an 
increase in oxidative phosphorylation occurring to power the Na+/K+ pump when neuronal 
activity evokes a Na+ influx through glutamate-gated receptors. Since Ca2+ release from 
stores by both IP3 receptors and ryanodine receptors depends on activation by cytoplasmic 
Ca2+ (Berridge, 2016), a rise in [Ca2+]i produced by any of the mechanisms above could 
synergise supralinearly with Ca2+ released from internal stores by noradrenaline, to generate 
more Ca2+ release from the stores than would occur if only noradrenaline release or only 
local release of fast neurotransmitters occurred (Fig. 1B). Alternatively, a rise in cyclic AMP 
level produced by local neuronal activity can potentiate IP3 receptor mediated Ca2+ release 
(Taylor, 2016) and thus potentiate the astrocyte [Ca2+]i rise evoked by noradrenaline 
activating 1 receptors. Metabotropic glutamate and GABAB receptors linked to adenylate 
cyclase inhibit rather than promote cAMP formation, but neuronal activity does release 
adenosine which could raise the cAMP level by activating astrocyte A2a receptors, and thus 
potentiate the response to noradrenaline. Future experiments will need to delineate in detail 
how the effects on astrocyte [Ca2+]i of activating 1 receptors are modulated by the activity of 
A2a, mGluR and GABAB receptors.  
 A further question for the future is whether [Ca2+]i elevations in astrocytes regulate 
neuronal function by releasing gliotransmitters that act on neuronal receptors to alter 
synapse strength or neuronal excitability. A possible alternative scenario is that astrocytes 
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alter neurotransmitter action on surrounding neurons cell-autonomously, as a result of [Ca2+]i 
changes altering the surface expression of neurotransmitter transporters (which regulate 
transmitter action in flies as in mammals: MacNamee et al., 2016), or perhaps of surface 
membrane enzymes that hydrolyse ATP, thus altering the level of neurotransmitters or 
adenosine reaching the surrounding neurons (Shigetomi et al., 2011; discussed in Bazargani 
& Attwell, 2016). Additionally, the reported increase of astrocyte volume evoked during 
arousal by noradrenaline activating  receptors (Sherpa et al., 2016), which may contribute 
to the decrease in extracellular volume seen during wake periods (Xie et al., 2013), may 
alter the concentration of neurotransmitters in the extracellular space. Establishing the 
mechanism of this swelling, which could reflect an increased ion influx into astrocytes or a 
decrease of Na/K pump activity, is an important issue for the future. 
 We have focused here on the actions of noradrenaline on astrocytes, but dopamine 
and 5-HT also evoke astrocyte [Ca2+]i rises that may similarly alter neuronal function. These 
rises can occur by the transmitters acting on receptors or, in a non-receptor manner, by 
intracellular oxidation and generation of reactive oxygen species that activate PLC to release 
Ca2+ from internal stores (Vaarmann et al., 2010; Jennings et al., 2016; Schipke et al., 
2011). Intriguingly, in the mammalian brain, astrocytes have also been suggested to regulate 
the release of noradrenaline from locus coeruleus neurons, using lactate as a gliotransmitter 
(Tang et al. 2013). 
To sum up, wide-ranging aminergic axons may be able to gate arousal and other 
behavioural changes by raising astrocyte [Ca2+]i levels. A key question raised by this work is 
the relative importance of amine signalling that is mediated by astrocytes, as opposed to 
mediated by direct effects of amine transmitters on neurons. The demonstration of amine-
regulated behaviour produced by astrocytes raises the possibility of new pharmacological 
targets for therapy, once the underlying mechanisms are completely understood. 
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Figure 1. Mechanisms and consequences of elevation of [Ca2+]i in astrocytes.  
(A) In Drosophila ventral nerve cord, Tdc2+ neurons releasing the adrenaline/noradrenaline 
analogues tyramine and octopamine activate the Oct/Tyr receptor on astrocytes that couples 
to Gq to activate PLC and generate IP3 from PIP2. Either the fall of PIP2 or the IP3-evoked 
release of Ca2+ from internal stores (ER) can open the TRP-like channel Water witch (Wtrw), 
which allows Ca2+ into the cell. The Oct/Tyr receptor can also activate Gi and modulate 
cAMP signalling, but the effect of this on Ca2+ signalling is unclear. As in rodents, 
mitochondria (Mito) might release Ca2+ via the mitochondrial permeability transition pore 
(mPTP). Ca2+ transients lead to a release of ATP (shown as vesicular), which is converted to 
adenosine (ADO) by ecto-ATPases. ADO activates receptors on dopaminergic neurons that 
stop those neurons firing action potentials, and thus inhibit dopamine release. Dopamine, in 
turn, inhibits chemotaxis and startle movements. (B) In rodents, noradrenaline release from 
locus coeruleus (LC) axons activates astrocyte 1 receptors which, via Gq and IP3, release 
Ca2+ from internal stores. Glutamate can release Ca2+ via a Gq-IP3 pathway, or by evoking a 
Na+ influx through ionotropic receptors or transporters thus raising [Na+]i and slowing Na/Ca 
exchange (NCX). Ca2+ may enter through ATP-gated P2X1 receptors, and by TRPA1 
channels but it is unclear whether TRPA1 can be gated by transmitters. Mitochondria supply 
ATP to the Na+/K+ pump, but also release Ca2+ through the mPTP, or release reactive 
oxygen species (ROS) which act on IP3 and ryanodine receptors (IP3R2 and RyR) to promote 
Ca2+ release from internal stores. Because Ca2+ release via IP3R2 and RyR requires 
activation by cytoplasmic Ca2+ (dashed lines), the Ca2+ release evoked by glutamate may 
potentiate the release evoked by noradrenaline (and vice versa). Neuronal activity may also 
potentiate Ca2+ release by generating ADO which raises [cAMP]i via A2a receptors. Ca2+ 
transients may evoke the release of gliotransmitters (ATP, D-ser, GABA, glutamate) which 
modulate the strength of nearby synapses and the excitability of neurons, or may alter 
trafficking of neurotransmitter transporters (GAT/GLT-1) or ecto-ATPases to the surface 
membrane. In this way, noradrenergic signalling can, via astrocyte-released gliotransmitters, 
alter signal processing over a large set of synapses, thus mediating attention and arousal. 
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